Skip to main content
. 2010 Jan 27;17(4):487–495. doi: 10.1128/CVI.00423-09

TABLE 1.

Characterization of the immune response elicited by OpaJ-containing liposomes adjuvanted with LpxL1 or PagL LPS as measured in ELISAs

Group LPS dose (μg) Anti-OpaJ titera
Nonspecific IgG titerb Nonspecific IgM titerb
IgG IgG1 IgG2a IgG2b IgG3 IgM
Not adjuvanted 3.5 3.4 0.4 0.8 0.3 2.1 2.2 1.7
AlPO4 3.6 3.6 0.8 1.9 1.0 2.5 0.6 1.5
LpxL1 coincorporated 1 4.0* 4.3* 2.0*§ 2.7* 1.8 0.6 0.6 0.6
Free LpxL1 1 4.1* 4.2 3.0*§ 3.2* 1.0 1.8 0.6 1.6
PagL coincorporated 1 3.8 3.4 2.7* 2.9* 1.3 0.6 0.3 0.6
Free PagL 1 3.8 4.1 3.2* 3.1* 1.3 2.3 0.6 1.7
PagL coincorporated 0.1 3.9 3.9 3.0* 3.0*§ 1.3 1.0 0.6 0.3
Free PagL 0.1 4.2* 4.1 3.3* 3.7*§ 1.0 1.6 0.6 0.8
a

The titer of each anti-OpaJ Ig was determined by whole-cell ELISA in plates coated with OpaJ+ cells of N. meningitidis strain H44/76 of immunotype L3. Data are expressed as the mean log10 titer. The results for the different groups were compared by ANOVA with a confidence level of 95% when appropriate. *, statistically significant differences compared with the nonadjuvanted group (P < 0.05). §, statistically significant differences between groups adjuvanted with free LPS or LPS coincorporated with OpaJ into the liposomes (P < 0.05).

b

The titer of each antiserum was determined by whole-cell ELISA in plates coated with OpaJ cells of N. meningitidis strain H44/76 of immunotype L3. Data are expressed as the mean log10 titer.